222 related articles for article (PubMed ID: 8141420)
1. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
2. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of brain oxytocin in modulating vasopressin antipyretic action.
Poulin P; Pittman QJ
Am J Physiol; 1993 Jul; 265(1 Pt 2):R151-6. PubMed ID: 8342681
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
Poulin P; Pittman QJ
J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
6. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
[TBL] [Abstract][Full Text] [Related]
7. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
Lebrun C; Le Moal M; Koob GF; Bloom FE
Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic blood flow autoregulation remains unaltered following surgical and pharmacological blockade of central vasopressin.
Sandor P; Petty M; de Jong W; Palkovits M; de Wied D
Brain Res; 1991 Dec; 566(1-2):212-8. PubMed ID: 1814538
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.
Saydoff JA; Rittenhouse PA; Carnes M; Armstrong J; Van De Kar LD; Brownfield MS
Am J Physiol; 1996 Mar; 270(3 Pt 1):E513-21. PubMed ID: 8638700
[TBL] [Abstract][Full Text] [Related]
11. Involvement of vasopressin in the cardiovascular effects of intracerebroventricularly administered alpha 1-adrenoceptor agonists in the conscious rat.
Hiwatari M; Johnston CI
J Hypertens; 1985 Dec; 3(6):613-20. PubMed ID: 2868056
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin receptors in the area postrema differentially modulate baroreceptor responses in rats.
Zhang X; Abdel-Rahman AR; Wooles WR
Eur J Pharmacol; 1992 Nov; 222(1):81-91. PubMed ID: 1468501
[TBL] [Abstract][Full Text] [Related]
13. Central and systemic effects of a vasopressin V1 antagonist on MAP recovery after haemorrhage in rats.
Johnson JV; Bennett GW; Hatton R
J Cardiovasc Pharmacol; 1988 Oct; 12(4):405-12. PubMed ID: 2465440
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin antagonist blocks the vasodepressor but not the vasopressor effect of neurohypophysial peptides in chickens.
Robinzon B; Koike TI; Marks PA
Peptides; 1994; 15(8):1407-13. PubMed ID: 7700844
[TBL] [Abstract][Full Text] [Related]
15. Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism.
Thornhill J; Gregor L; Pittman Q
Regul Pept; 1990 Oct; 31(1):1-10. PubMed ID: 1980152
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin: mechanism of central cardiovascular action in conscious rats.
Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
[TBL] [Abstract][Full Text] [Related]
17. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
Shimizu K; Schwartz J; McGrath BP
Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
[TBL] [Abstract][Full Text] [Related]
18. Central injections of arginine vasopressin prolong extinction of active avoidance.
Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
[TBL] [Abstract][Full Text] [Related]
19. Participation of arginine vasopressin-mediated and adrenergic system-mediated mechanisms in the hypertension induced by intracerebroventricular administration of NMDA in freely moving rats.
Maione S; Vitagliano S; Berrino L; Lampa E; Rossi F
Neuropharmacology; 1992 Apr; 31(4):403-7. PubMed ID: 1355901
[TBL] [Abstract][Full Text] [Related]
20. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
de Wied D; Elands J; Kovács G
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
